NeuroNOS

Boston, United States

NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.

$2.0M raised

Mar 2025

Seed

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuroNOS

How much funding has NeuroNOS raised?

NeuroNOS has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in March 2025.

Where is NeuroNOS headquartered?

NeuroNOS is headquartered in Boston, United States.

What does NeuroNOS do?

NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.

What stage is NeuroNOS at?

NeuroNOS is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2025.

MLA

"NeuroNOS — Funding & Investors." VCBacked, March 24, 2025, https://www.vcbacked.co/company/neuronos. Accessed June 13, 2026.

APA

VCBacked. (2025). NeuroNOS — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/neuronos

Wikipedia (cite web)

{{cite web |title=NeuroNOS — Funding & Investors |url=https://www.vcbacked.co/company/neuronos |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2025.